《大行報告》里昂升信義玻璃(00868.HK)評級至「買入」 目標價上調至11.1元
里昂發表研究報告指,考慮到去年上半年的一次性收益,信義玻璃(00868.HK)發盈警屬預期之內。
報告指出,由於需求增加及市場庫存減少,浮法玻璃5月價格大幅反彈,較4月底低位升約19%,加上下半年物業竣工旺季來臨,預期「V型」格局將會進一步延續;又估計除純鹼(soda ash)價格下跌外,未來幾個月燃料成本亦有機會下降。
里昂調高信義玻璃2020至2022年核心盈利預測17.4%、12.6%及12.3%,預期產品平均價格及毛利率均有上升空間,並將目標價由9.7元上調至11.1元,評級由「跑贏大市」上調至「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.